Catalyst Wire Dossier Catalyst Wire Dossier

rifaximin vaginal tablets

rifaximin · Alfasigma S.p.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rifaximin vaginal tablets, covering 2016-10-10 to 2016-10-10. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of Rifaximin Vaginal Tablets in Bacterial Vaginosis [Phase 2]

See pricing